Jonathan James: Amplifying Voices Across the Bleeding Disorders Community
Jonathan James, President and CEO at Hope Charities, shared a post on LinkedIn:
“I had the honor of sitting down for a long conversation with a friend of mine who is making a big difference in the lives of people living with Hemophilia and other chronic illnesses.
Patrick James Lynch has been a voice for the voiceless and continues to make an impact by sharing the stories of people who are often unseen and overlooked.
His podcasts on BloodStream Media are making strides to unveil challenges while educating people across many walks of life about the needs and barriers that often are overlooked and underappreciated.
In our discussion, we talked about many things in life, such as global access issues, aging with a bleeding disorder, personal challenges, and communal success.
It was truly a privilege to have this conversation, and I hope that you will take some time to listen to this conversation.
Spoiler alert, there are several ‘never shared before details’ in this one.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH